Curevac to report fourth quarter and full-year 2024 financial results and business update on april 10, 2025

TÜbingen, de / access newswire / april 8, 2025 / curevac n.v. (nasdaq:cvac) ("curevac"), a global biotech company developing a new class of transformative medicines based on messenger ribonucleic acid ("mrna"), will report financial results, and provide business updates for the fourth quarter and full-year 2024 on thursday, april 10, 2025.

CVAC Ratings Summary

CVAC Quant Ranking